These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drugs can reduce the incidence of breast cancer: now what? Wozniak TF, Eppes PG, Wilson CT. Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440 [No Abstract] [Full Text] [Related]
8. Raloxifene for the treatment and prevention of breast cancer? Pappas SG, Jordan VC. Expert Rev Anticancer Ther; 2001 Oct; 1(3):334-40. PubMed ID: 12113100 [Abstract] [Full Text] [Related]
9. [Raloxifene (Celvista, Evista)]. Body JJ, Sternon J. Rev Med Brux; 2000 Feb; 21(1):35-41. PubMed ID: 10748686 [Abstract] [Full Text] [Related]
11. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women. Bevers TB. J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929 [Abstract] [Full Text] [Related]
12. Selective estrogen-receptor modulators for primary prevention of breast cancer. Fabian CJ, Kimler BF. J Clin Oncol; 2005 Mar 10; 23(8):1644-55. PubMed ID: 15755972 [No Abstract] [Full Text] [Related]
13. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer. Runowicz CD. Health News; 2003 Apr 10; 9(4):1-2. PubMed ID: 12710388 [No Abstract] [Full Text] [Related]
15. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis? Hathirat S, Evans MF. Can Fam Physician; 2001 Oct 10; 47():1982-4. PubMed ID: 11723592 [No Abstract] [Full Text] [Related]